Fig. 4

Changes of HOMA-IR, Adipo-IR, and HOMA-AD of the prediabetes and diabetes subgroups in the standard and intensive treatment groups from baseline after intervention. HOMA-IR, homeostatic model assessment of insulin resistance; Adipo-IR, adipose tissue insulin resistance; HOMA-AD, homeostasis model assessment-adiponectin. A Changes of HOMA-IR in the standard treatment group from baseline after intervention. B Changes of HOMA-IR in the intensive treatment group from baseline after intervention. C Changes of Adipo-IR in the standard treatment group from baseline after intervention. D Changes of Adipo-IR in the intensive treatment group from baseline after intervention. E Changes of HOMA-AD in the standard treatment group from baseline after intervention. F Changes of HOMA-AD in the intensive treatment group from baseline after intervention. P values were assessed by comparing the values before and after intervention using Wilcoxon signed-rank test